Invesco has launched its first fund investing in Chinese healthcare companies set to benefit from key growth trends such as preimmunization and reform.
The China Healthcare Equity Fund is said to “embrace the take-off” of China’s healthcare sector, according to Chin Ping Chia, head of China A investments, business strategy and development.
“The China healthcare sector has strong potential to expand due to robust growth in healthcare spending underpinned by a rise in wealth and an ageing population, making healthcare a hugely important sector for China’s society and economy,” he said.
Managed by senior fund manager Chris Liu in Hong Kong, the strategy focuses on healthcare mid-cap stocks, investing in businesses across five sub sectors including medical devices, drug manufacturing, medical services and vaccine producers.
A Ucits-compliant Sicav, the portfolio will typically consist of between 30-40 stocks, according to Invesco.
Although companies will mainly be listed on the Shanghai or Shenzhen stock exchanges and traded via Stock Connect, the fund may also invest in securities listed or traded on other international exchanges.
© 2021 funds global asia